Cargando…
New SMARCA2 mutation in a patient with Nicolaides–Baraitser syndrome and myoclonic astatic epilepsy
We report a de novo SMARCA2 missense mutation discovered on exome sequencing in a patient with myoclonic astatic epilepsy, leading to reassessment and identification of Nicolaides–Baraitser syndrome. This de novo SMARCA2 missense mutation c.3721C>G, p.Gln1241Glu is the only reported mutation on e...
Autores principales: | Tang, S., Hughes, E., Lascelles, K., Simpson, M. A., Pal, D. K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516167/ https://www.ncbi.nlm.nih.gov/pubmed/27665729 http://dx.doi.org/10.1002/ajmg.a.37935 |
Ejemplares similares
-
Paradoxical exacerbation of myoclonic-astatic seizures by levetiracetam in myoclonic astatic epilepsy
por: Makke, Yamane, et al.
Publicado: (2015) -
New insights into DNA methylation signatures: SMARCA2 variants in Nicolaides-Baraitser syndrome
por: Chater-Diehl, Eric, et al.
Publicado: (2019) -
A SMARCA2 Mutation in the First Case Report of Nicolaides-Baraitser Syndrome in Latin America: Genotype-Phenotype Correlation
por: Sánchez, Ana Isabel, et al.
Publicado: (2017) -
Ten‐year follow‐up of Nicolaides–Baraitser syndrome with a de novo mutation and analysis of 58 gene loci of SMARCA2‐associated NCBRS
por: Zhang, Xilian, et al.
Publicado: (2022) -
Autism spectrum disorder in a patient with Nicolaides-Baraitser Syndrome: case report
por: Lopes, Derek Chaves, et al.
Publicado: (2023)